By Jesse Newman Beyond Meat said Friday that the head of its human resources team would be departing, the latest in a string of executives to part ways with the plant-based-burger maker. In an filing to the U.S. Securities and Exchange Commission, Beyond said its chief people officer, Margaret Trask,…

Stock Picking Is Not For Everyone I am a stock picker at heart, but I also appreciate that stock selection is challenging for many investors because of emotional biases, a lack of competence, and the difficulties of timing the market. Many private investors may lack the time or knowledge to…

By Ben Glickman A Lockheed Martin subsidiary has received a $1.2 billion contract modification from the U.S. Navy for Trident II missile production and deployment systems support. Work by Lockheed Martin Space, based in Titusville, Fla., is expected to be completed by Sept. 30, 2028. Write to Ben Glickman at…

For this month, the cycle/relative strength concept is applied. First, the Dow Jones 30 stocks are ranked from the best performer to the worst by calculating the expected return in that month. The top best traditional performers in the month were then screened for relative strength by a unique measure…

By Ben Glickman The Food and Drug Administration gave de novo marketing authorization to a diagnostic test that can help detect genes associated with elevated risk of developing cancers. The FDA said that the test, called the Invitae Common Hereditary Cancers Panel, was an in vitro diagnostic test designed to…

By Ben Glickman Shares of Syra Health continued their slide after-hours Friday following the company’s first day of trading. The stock was down 8% to $2.76 in after-hours trading. Shares closed at $3, 27% below the company’s pricing per offering unit of $4.125. The Carmel, Ind.-based healthcare consulting company’s shares…

The harsh market climate of August and September has left quite a few stocks selling for what I consider bargain prices. Welcome to the 82nd quarterly Casualty List, featuring stocks that have been knocked around and that I think have the potential to recover and thrive. RTX I’ll start with…

By Ben Glickman Oragenics said it would transfer assets to Lantern Bioworks. Oragenics said it would receive $50,000 in cash, the right to acquire 1 million Lantern shares and 10% of the profits from the assets over the next decade. Shares rise 18%, to $3.51, after-hours. Natuzzi said it would…

Retail buyers have a poor grasp of closed-end investment companies. That creates opportunities for Florida money man Erik Herzfeld. By William Baldwin, Senior Contributor Classical economics: All actors are rational. Stocks are efficiently priced. Behavioral economics, per Nobelist Richard Thaler: Investors’ decisions are warped by emotion and ignorance. Prices can…

Hi! In this week’s ETF Wrap, you’ll get see how international stocks, including in emerging markets, stack up against U.S. equities in the third quarter.Please send feedback and tips to [email protected] or [email protected]. You can also follow me on Twitter at @cidzelis and find me on LinkedIn. Isabel Wang is on Twitter at @Isabelxwang.…